BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17267510)

  • 1. Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2.
    Griffiths R; Whitehouse A
    J Virol; 2007 Apr; 81(8):4021-32. PubMed ID: 17267510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ORF73 of herpesvirus Saimiri strain C488 tethers the viral genome to metaphase chromosomes and binds to cis-acting DNA sequences in the terminal repeats.
    Verma SC; Robertson ES
    J Virol; 2003 Dec; 77(23):12494-506. PubMed ID: 14610173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
    Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
    J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence.
    Calderwood M; White RE; Griffiths RA; Whitehouse A
    J Gen Virol; 2005 Oct; 86(Pt 10):2703-2708. PubMed ID: 16186223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpesvirus saimiri.
    Fickenscher H; Fleckenstein B
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):545-67. PubMed ID: 11313011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication.
    Schäfer A; Lengenfelder D; Grillhösl C; Wieser C; Fleckenstein B; Ensser A
    J Virol; 2003 May; 77(10):5911-25. PubMed ID: 12719584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the minimal regions within the ORF73 protein required for herpesvirus saimiri episomal persistence.
    Griffiths R; Harrison SM; Macnab S; Whitehouse A
    J Gen Virol; 2008 Nov; 89(Pt 11):2843-2850. PubMed ID: 18931082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells.
    Burnside KL; Ryan JT; Bielefeldt-Ohmann H; Gregory Bruce A; Thouless ME; Tsai CC; Rose TM
    Virology; 2006 Oct; 354(1):103-15. PubMed ID: 16879850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the herpesvirus saimiri ORF73 gene product.
    Hall KT; Giles MS; Goodwin DJ; Calderwood MA; Markham AF; Whitehouse A
    J Gen Virol; 2000 Nov; 81(Pt 11):2653-2658. PubMed ID: 11038376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus.
    Calderwood MA; Hall KT; Matthews DA; Whitehouse A
    J Gen Virol; 2004 Jan; 85(Pt 1):147-153. PubMed ID: 14718629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulator protein CTCF binding sites in the orf73/LANA promoter region of herpesvirus saimiri are involved in conferring episomal stability in latently infected human T cells.
    Zielke K; Full F; Teufert N; Schmidt M; Müller-Fleckenstein I; Alberter B; Ensser A
    J Virol; 2012 Feb; 86(3):1862-73. PubMed ID: 22130528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ORF73 of herpesvirus saimiri, a viral homolog of Kaposi's sarcoma-associated herpesvirus, modulates the two cellular tumor suppressor proteins p53 and pRb.
    Borah S; Verma SC; Robertson ES
    J Virol; 2004 Oct; 78(19):10336-47. PubMed ID: 15367600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The herpesvirus saimiri ORF 73 regulatory region provides long-term transgene expression in human carcinoma cell lines.
    Giles MS; Smith PG; Coletta PL; Hall KT; Whitehouse A
    Cancer Gene Ther; 2003 Jan; 10(1):49-56. PubMed ID: 12489028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpesvirus saimiri open reading frame 50 (Rta) protein reactivates the lytic replication cycle in a persistently infected A549 cell line.
    Goodwin DJ; Walters MS; Smith PG; Thurau M; Fickenscher H; Whitehouse A
    J Virol; 2001 Apr; 75(8):4008-13. PubMed ID: 11264393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73.
    Gao J; Coulson JM; Whitehouse A; Blake N
    J Virol; 2009 Jan; 83(1):273-82. PubMed ID: 18945762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32.
    Hall KT; Giles MS; Calderwood MA; Goodwin DJ; Matthews DA; Whitehouse A
    J Virol; 2002 Nov; 76(22):11612-22. PubMed ID: 12388722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence.
    Komatsu T; Ballestas ME; Barbera AJ; Kelley-Clarke B; Kaye KM
    Virology; 2004 Feb; 319(2):225-36. PubMed ID: 14980483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episomal replication timing of gamma-herpesviruses in latently infected cells.
    Vogel B; Full F; Biesinger B; Linden C; Alberter B; Ensser A
    Virology; 2010 May; 400(2):207-14. PubMed ID: 20172574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome.
    Collins CM; Medveczky MM; Lund T; Medveczky PG
    J Gen Virol; 2002 Sep; 83(Pt 9):2269-2278. PubMed ID: 12185282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient infection and persistence of a herpesvirus saimiri-based gene delivery vector into human tumor xenografts and multicellular spheroid cultures.
    Smith PG; Burchill SA; Brooke D; Coletta PL; Whitehouse A
    Cancer Gene Ther; 2005 Mar; 12(3):248-56. PubMed ID: 15540115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.